Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Other Non-Current Liabilities: 2020

Historic Other Non-Current Liabilities for Protagonist Therapeutics (PTGX) over the last 1 years, with Dec 2020 value amounting to $121,000.

  • Protagonist Therapeutics' Other Non-Current Liabilities fell 28.82% to $121,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $121,000, marking a year-over-year decrease of 28.82%. This contributed to the annual value of $121,000 for FY2020, which is N/A change from last year.
  • Latest data reveals that Protagonist Therapeutics reported Other Non-Current Liabilities of $121,000 as of FY2020.
  • In the past 5 years, Protagonist Therapeutics' Other Non-Current Liabilities registered a high of $121,000 during FY2020, and its lowest value of $121,000 during FY2020.
  • For the 1-year period, Protagonist Therapeutics' Other Non-Current Liabilities averaged around $121,000, with its median value being $121,000 (2020).